Anzeige
Mehr »
Login
Samstag, 29.03.2025 Börsentäglich über 12.000 News von 696 internationalen Medien
Ad-hoc-News: Wieder Verdopplung? Montag massiver Turnaround und komplette Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PLRC | ISIN: KYG549581067 | Ticker-Symbol: 3KY
Tradegate
28.03.25
18:42 Uhr
2,900 Euro
+0,040
+1,40 %
Branche
Pharma
Aktienmarkt
HANG SENG
1-Jahres-Chart
HANSOH PHARMACEUTICAL GROUP CO LTD Chart 1 Jahr
5-Tage-Chart
HANSOH PHARMACEUTICAL GROUP CO LTD 5-Tage-Chart
RealtimeGeldBriefZeit
2,7802,88013:04
2,8402,88028.03.

Aktuelle News zur HANSOH PHARMACEUTICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FrHSI Closes at 23,426, Down 152 pts; HSTI Closes at 5,506, Down 82 pts; HAIER SMARTHOME Down over 7%; HANSOH PHARMA, YIXIN, CHINA EAST EDU, LONKING, CRYSTAL INTL Hit New Highs; Market Turnover Rises3
HANSOH PHARMACEUTICAL Aktie jetzt für 0€ handeln
FrHSI Closes Midday at 23,368, Down 210 pts; HSTI Closes Midday at 5,495, Down 93 pts; HAIER SMARTHOME Down over 7%; HANSOH PHARMA, ZAI LAB, CHINA EAST EDU, 3SBIO, CRYSTAL INTL Hit New Highs18
21.03.HANSOH PHARMA (03692): FINAL DIVIDEND FOR THE YEAR ENDED DECEMBER 31, 20244
21.03.HANSOH PHARMA (03692): ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 20242
10.03.HANSOH PHARMA (03692): DATE OF BOARD MEETING1
10.03.HANSOH PHARMA (03692): VOLUNTARY ANNOUNCEMENT - DRUG REGISTRATION APPROVAL OF THE THIRD INDICATION OF AMEILE (AUMOLERTINIB MESILATE TABLETS) WAS GRANTED ...1
04.03.HANSOH PHARMA (03692): VOLUNTARY ANNOUNCEMENT - THE SECOND BIOLOGICS LICENSE APPLICATION OF XINYUE (INEBILIZUMAB INJECTION) WAS ACCEPTED BY THE NATIONAL ...3
27.02.Silence slows phase 3 plans for cardio drug, as Hansoh opts out of $1.3B biobucks collab3
25.02.HANSOH PHARMA (03692): VOLUNTARY ANNOUNCEMENT - THE NMPA HAS GRANTED BREAKTHROUGH-THERAPY-DESIGNATED DRUG FOR B7-H3-TARGETED ANTIBODY-DRUG CONJUGATE HS-20093 ...1
25.02.HANSOH PHARMA (03692): VOLUNTARY ANNOUNCEMENT - THE CLINICAL TRIAL APPROVAL FOR HS-10561 CAPSULES ISSUED BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION1
10.02.HANSOH PHARMA (03692): VOLUNTARY ANNOUNCEMENT - A NEW INDICATION OF XINYUE (INEBILIZUMAB INJECTION) INCLUDED IN PRIORITY REVIEW AND APPROVAL PROCEDURE2
29.01.Leichte Zugewinne bei der Hansoh Pharmaceutical-Aktie (2,28 €)291Im Plus liegt gegenwärtig der Anteilsschein von Hansoh Pharmaceutical . Zuletzt zahlten Investoren für das Wertpapier 2,28 Euro. Jahreschart der Hansoh Pharmaceutical-Aktie, Stand 29.01.2025 Für der...
► Artikel lesen
24.01.HANSOH PHARMA (03692): CHANGES OF JOINT COMPANY SECRETARY, AUTHORIZED REPRESENTATIVE AND PROCESS AGENT1
10.01.HANSOH PHARMA (03692): CHANGE OF PRINCIPAL PLACE OF BUSINESS IN HONG KONG1
07.01.HANSOH PHARMA (03692): VOLUNTARY ANNOUNCEMENT - B7-H3-TARGETED ANTIBODY-DRUG CONJUGATE HS-20093 RECEIVED FDA BREAKTHROUGH THERAPY DESIGNATION IN LATE-LINE ...2
19.12.24MSD makes obesity play in up to $2bn deal for Hansoh's GLP-1RA asset6
19.12.24Merck gains rights to Hansoh's preclinical GLP-1 candidate in deal worth $2bn5
19.12.24Merck Enters Obesity Space, Buys Rights to Hansoh's Oral GLP-1 Drug3
19.12.24MSD makes its obesity move with $2bn Hansoh deal3
18.12.24Merck moves into obesity with deal for Hansoh's GLP-1 pill6
Seite:  Weiter >>
66 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1